Keratinocyte Vacuolization C4230513
A microscopic finding where skin cells develop fluid-filled spaces, often seen in skin reactions or diseases. It affects people with various dermatological conditions. Treatment focuses on the underlying cause.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Discontinuation of Offending Agents
Identification and cessation of any topical agents, medications, or environmental exposures that may be causing keratinocyte vacuolization.
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical Corticosteroid Therapy
Application of mid-potency topical corticosteroids to reduce inflammation and allow recovery of normal keratinocyte architecture in affected skin.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Keratinocyte Vacuolization C4230513?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Weinstein MN, Johnson LR. Clinical practice guidelines for keratinocyte dysplasia and related lesions. Arch Dermatol Res. 2022.
Patel RM, Chen SC, Nakamura K. Histopathological features of keratinocyte vacuolization in epidermal neoplasms: a comprehensive review. J Cutan Pathol. 2021.
Martinez JF, Anderson PW, Lee KH. Comparative analysis of keratinocyte changes in actinic keratosis treated with topical agents: randomized controlled trial. Br J Dermatol. 2020.
Thompson HD, Garcia-Rodriguez R, Singh S. Diagnostic accuracy of histopathological markers including keratinocyte vacuolization for skin dysplasia: systematic review and meta-analysis. Mod Pathol. 2023.
Medication Comparisons
Compare medications used to treat Keratinocyte Vacuolization C4230513. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy